JSPR vs MSFT: Which Stock is Better?
Side-by-side comparison of Jasper Therapeutics Inc and Microsoft Corp in 2026
JSPR
Jasper Therapeutics Inc
$1.05
MSFT
Microsoft Corp
$415.05
Key Metrics Comparison
| Metric | JSPR | MSFT | Winner |
|---|---|---|---|
| Market Cap | $26.10M | N/A | JSPR |
| P/E Ratio | N/A | 24.57 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze JSPR
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JSPR or MSFT a better investment?
Comparing JSPR and MSFT: Jasper Therapeutics Inc has a market cap of $26.10M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JSPR and MSFT?
JSPR (Jasper Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JSPR or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JSPR or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for JSPR.
Which company is more profitable: JSPR or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for JSPR.
Which is the larger company: JSPR or MSFT?
Jasper Therapeutics Inc (JSPR) is larger with a market cap of $26.10M compared to N/A for MSFT.
Should I buy JSPR or MSFT in 2026?
Both JSPR and MSFT have investment merit. JSPR trades at $1.05 while MSFT trades at $415.05. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JSPR and MSFT stock?
Key differences: Market Cap ($26.10M vs N/A), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).